Low red blood cell counts almost always trace back to one of three problems: your body isn’t making enough new red blood cells, it’s destroying them faster than it can replace them, or you’re losing them through bleeding. Within those three buckets sit dozens of specific causes, from something as straightforward as not getting enough iron in your diet to conditions as complex as bone marrow failure. Understanding which category your situation falls into is the first step toward fixing it, and the distinctions matter because treatments vary dramatically depending on the root cause.
How Red Blood Cells Get Made in the First Place
Your bone marrow churns out red blood cells continuously, releasing roughly two million new ones into your bloodstream every second. The process is driven by a hormone called erythropoietin (EPO), which your kidneys produce in response to low oxygen levels. When your tissues sense they aren’t getting enough oxygen, EPO production ramps up and signals the bone marrow to accelerate red blood cell manufacturing.1PubMed Central. Erythropoietin regulation of red blood cell production: from bench to bedside and back Each red blood cell circulates for about 120 days before aging out and being cleared by the spleen and liver. Anything that disrupts this balance between production and removal can leave you with fewer red blood cells than you need.
EPO does more than just speed up production. Research in mice has shown that rising EPO levels also extend the lifespan of red blood cells already in circulation by reducing how aggressively macrophages (the immune cells responsible for clearing old red blood cells) consume them.2PubMed Central. A new role for erythropoietin in the homeostasis of red blood cells So EPO acts as both an accelerator for new cell production and a brake on the removal of existing cells. When something goes wrong with EPO signaling, the consequences compound from both directions.
Iron Deficiency
Iron deficiency is the single most common reason people develop anemia worldwide. Most of your body’s iron is tied up inside hemoglobin, the oxygen-carrying protein packed into every red blood cell. When iron levels drop, your bone marrow can’t build hemoglobin efficiently, and the red blood cells it produces come out smaller and paler than normal.3PubMed Central. Recommendations for diagnosis, treatment, and prevention of iron deficiency and iron deficiency anemia Blood loss is the most frequent trigger for iron depletion because each red blood cell that leaves your body takes its iron with it. Heavy menstrual periods, gastrointestinal bleeding from ulcers or polyps, and even frequent blood donations can all drain iron stores over time.
Diet plays a role too, though it tends to be a slower path to deficiency. People who eat very little red meat, vegetarians, and vegans absorb less of the highly bioavailable form of iron found in animal products. Pregnancy creates a double hit: the growing fetus needs iron for its own blood supply while the mother’s blood volume expands dramatically. Poor absorption in the gut rounds out the list of common drivers, and conditions like celiac disease are frequently discovered during workups for unexplained iron deficiency anemia.4PubMed Central. A short review of malabsorption and anemia
B12 and Folate Deficiency
Iron isn’t the only nutrient your bone marrow needs. Vitamin B12 and folate are essential for DNA synthesis inside developing red blood cells. When either is lacking, the cells can’t divide properly. Instead of producing a normal number of healthy cells, the marrow generates fewer, abnormally large red blood cells that don’t function well.5Annual Reviews. New insights into erythropoiesis: the roles of folate, vitamin B12, and iron The medical term for this is megaloblastic anemia, but the practical takeaway is straightforward: without these vitamins, your body wastes a lot of effort making red blood cells that never survive to maturity.
B12 deficiency has some distinctive features. It often stems from poor absorption rather than poor intake, because the stomach produces a protein called intrinsic factor that B12 needs in order to be absorbed in the small intestine. Older adults, people who’ve had stomach surgery, and those with autoimmune gastritis all have trouble with this step. Folate deficiency, on the other hand, is more often dietary. It’s common in people who eat very few vegetables and in heavy alcohol users, since alcohol interferes with folate absorption and metabolism.
Gut Problems That Block Nutrient Absorption
Even if your diet is perfectly balanced, malabsorption in the gut can prevent iron, B12, and folate from ever reaching your bloodstream. Celiac disease is one of the best-studied examples. Anemia is frequently a complication in celiac patients and is sometimes the first clue that the disease is present, with iron deficiency anemia reported in a sizable fraction of celiac diagnoses.4PubMed Central. A short review of malabsorption and anemia Gastric bypass and other bariatric surgeries can have a similar effect because they physically reroute or reduce the surface area of the intestine available for absorption.
Inflammatory bowel disease, chronic infections of the gut, and conditions that speed up transit time through the intestines can all reduce how much nutrition you extract from food. What makes malabsorption tricky is that the anemia it causes can look like a simple dietary deficiency on blood tests, and the underlying gut problem may not produce obvious digestive symptoms for years.
Chronic Disease and Inflammation
If you have a long-running inflammatory condition, whether that’s rheumatoid arthritis, lupus, heart failure, cancer, or a chronic infection, your body may deliberately restrict the iron supply to your bone marrow. This sounds counterproductive, and in a sense it is, but it’s actually an ancient defense mechanism. During infection or inflammation, the immune system produces a hormone called hepcidin that locks iron inside storage cells and prevents it from being absorbed in the gut.6PubMed Central. Iron sequestration and anemia of inflammation The evolutionary logic is to starve invading bacteria of the iron they need to grow. The collateral damage is that your bone marrow gets starved of iron too.
The inflammatory cytokine interleukin-6 is a particularly strong trigger of hepcidin production, though other inflammatory signals contribute as well.7PubMed Central. Anemia of Inflammation: A Review This type of anemia tends to be mild to moderate and is usually normocytic, meaning the red blood cells are normal in size but just fewer in number. The frustrating part is that you may have plenty of iron stored in your body; it’s simply being held hostage. Standard iron supplements often don’t help much here, because the problem isn’t a lack of iron in the body but a refusal to release it.
Kidney Disease
Your kidneys are the primary factory for erythropoietin. When chronic kidney disease (CKD) damages the kidney tissue, the specialized cells that produce EPO transform into scar-tissue-forming cells and progressively lose their ability to make the hormone.8PubMed. Physiology and pathophysiology of renal erythropoietin-producing cells Without adequate EPO, the bone marrow receives a weaker and weaker signal to make red blood cells, and production gradually declines. People with advanced CKD almost universally develop anemia, and it often appears well before the kidneys fail completely.
This is one of the few causes of low red blood cells that has a fairly direct pharmaceutical fix: synthetic EPO injections (erythropoiesis-stimulating agents) can partially compensate for what the kidneys no longer provide. But timing and dosing matter a great deal, and iron deficiency often coexists, so treatment usually involves multiple approaches at once.
When Red Blood Cells Are Destroyed Too Fast
Sometimes the bone marrow is doing its job perfectly well, but red blood cells are being destroyed faster than they can be replaced. This broad category is called hemolytic anemia, and it splits into causes that come from inside the red blood cell and causes that attack it from outside.
Autoimmune Destruction
In autoimmune hemolytic anemia, your immune system mistakenly produces antibodies that target your own red blood cells, marking them for destruction by macrophages or by the complement system (a cascade of proteins that puncture cell membranes).9PubMed Central. Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy The warm type, which accounts for the majority of cases, involves antibodies that are most active at body temperature and typically coat red blood cells with markers that signal macrophages to consume them.10PubMed. Differential red blood cell age fractionation and Band 3 phosphorylation distinguish two different subtypes of warm autoimmune hemolytic anemia The cold type involves antibodies that activate at lower temperatures, usually in your fingers, toes, and nose.
Autoimmune hemolytic anemia can appear on its own or as a complication of other autoimmune diseases, lymphomas, or certain infections. It’s rare but can cause dramatic, rapid drops in red blood cell counts that require urgent treatment.11PubMed. Autoimmune Hemolytic Anemia and Red Blood Cell Autoantibodies
Inherited Red Blood Cell Defects
Some people are born with red blood cells that are structurally fragile or functionally impaired. Sickle cell disease produces hemoglobin that distorts red blood cells into rigid, crescent-shaped forms that get stuck in small blood vessels and break apart prematurely.12PubMed. Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia Thalassemias involve reduced production of one of hemoglobin’s protein chains, leading to imbalanced, unstable hemoglobin and chronic red blood cell destruction.
Other inherited conditions affect the red blood cell membrane or internal enzymes. Enzyme deficiencies, such as glucose-6-phosphate dehydrogenase (G6PD) deficiency, leave red blood cells unable to protect themselves from oxidative damage. When the cell’s protective systems fail, the membrane breaks down and macrophages clear the damaged cells from circulation.13Molecular Aspects of Medicine. Hemolytic anemias due to erythrocyte enzyme deficiencies G6PD deficiency is one of the most common genetic conditions in the world, affecting hundreds of millions of people, and often goes unnoticed until a trigger like certain medications, infections, or fava beans provokes a hemolytic episode.
Bone Marrow Failure
In aplastic anemia, the bone marrow itself is damaged or suppressed to the point where it can’t produce enough of any blood cell type, not just red blood cells. The result is a drop in red blood cells, white blood cells, and platelets all at once.14Hindawi / PubMed Central. Mesenchymal Stem Cell Benefits Observed in Bone Marrow Failure and Acquired Aplastic Anemia Acquired aplastic anemia is often triggered by an autoimmune attack on the marrow itself, though some cases follow exposure to toxic chemicals, radiation, or certain drugs. In many cases, no specific trigger is identified.
Bone marrow infiltration is a related problem. Cancers that start in the marrow (like leukemia or myeloma) or spread there from elsewhere can physically crowd out the normal blood-forming cells. The marrow becomes so packed with abnormal cells that there isn’t room or resources left to produce healthy red blood cells. Myelodysplastic syndromes, a group of conditions in which the marrow produces defective cells that die before maturing, also fall into this category.
Medications and Cancer Treatment
Chemotherapy is one of the most predictable causes of low red blood cells. Most chemotherapy drugs work by targeting rapidly dividing cells, and the blood-forming cells in your bone marrow are among the fastest-dividing cells in your body. The result is myelosuppression: the marrow’s output drops across all cell lines. In cancer patients receiving active treatment, this suppression of red blood cell production is often the dominant cause of anemia, though iron deficiency frequently coexists and compounds the problem.15PubMed Central. Anemia in patients receiving anticancer treatments: focus on novel therapeutic approaches
Chemotherapy isn’t the only pharmaceutical culprit. Certain antibiotics, anticonvulsants, and antiretroviral drugs can suppress the bone marrow or trigger immune-mediated red blood cell destruction. Some medications cause oxidative damage to red blood cells, especially in people with underlying G6PD deficiency. If you develop anemia while on a new medication, your doctor will usually consider the drug as a possible cause.
Blood Loss You Might Not Notice
Acute blood loss from surgery, trauma, or childbirth is obvious. What catches people off guard is chronic, low-grade blood loss that drains red blood cells so slowly you don’t realize it’s happening. A stomach ulcer oozing a small amount of blood daily, colon polyps that bleed intermittently, or heavy menstrual periods month after month can gradually empty your iron stores and reduce your red blood cell count without any dramatic event.
Because most of the body’s iron resides inside hemoglobin, blood loss is functionally the fastest route to iron depletion.3PubMed Central. Recommendations for diagnosis, treatment, and prevention of iron deficiency and iron deficiency anemia This is why iron deficiency anemia in men and postmenopausal women almost always prompts a search for hidden gastrointestinal bleeding. In premenopausal women, menstruation is the usual suspect, but GI sources should still be considered if periods are not particularly heavy.
Splenic Sequestration
The spleen acts as a quality-control filter for your blood, removing old or damaged red blood cells. When the spleen enlarges, a condition called hypersplenism, it becomes overly aggressive, trapping and destroying red blood cells prematurely.16PubMed Central. Hypersplenism: History and current status Liver cirrhosis is one of the most common causes of an enlarged spleen because the increased pressure in the portal vein backs blood up into the spleen. Lymphomas, certain infections, and storage diseases can also cause the spleen to enlarge. The anemia from hypersplenism tends to be mild, but it’s often accompanied by low platelet and white blood cell counts as well.
Pregnancy
During pregnancy, your blood volume expands substantially, but the increase in plasma (the liquid part of blood) outpaces the increase in red blood cells. The result is a natural dilution effect: your hemoglobin concentration drops even though the total number of red blood cells may actually rise slightly.17PubMed Central. Complications of anemia in pregnancy: An updated overview for healthcare professionals This physiological dip is most pronounced in the second trimester and serves a purpose, as the thinner blood flows more easily through the placenta.
However, true anemia in pregnancy is common too. The fetus draws heavily on the mother’s iron and folate stores, and many women enter pregnancy with marginal reserves. This is why prenatal vitamins with iron and folate are standard care. The challenge is distinguishing the normal dilutional drop in hemoglobin from a genuinely problematic deficiency, which is why doctors use trimester-specific thresholds when evaluating pregnant patients.
Aging and Unexplained Anemia
Anemia becomes increasingly common with age. Some of this is attributable to identifiable causes: chronic diseases pile up, kidney function declines, nutritional deficiencies become more prevalent, and bone marrow slowly loses its regenerative capacity. But in a substantial fraction of older adults, roughly a third of cases by some estimates, no clear explanation emerges even after thorough testing.18PubMed Central. Unexplained Anemia in the Elderly This “unexplained anemia of the elderly” is thought to involve low-grade chronic inflammation related to aging itself, subtle declines in stem cell function, and hormonal changes. A portion of these cases may reflect early, pre-cancerous changes in bone marrow stem cells that haven’t yet declared themselves as a recognizable blood disorder.
Red Blood Cells That Self-Destruct
Beyond being cleared by the immune system or physically lost through bleeding, red blood cells have a built-in self-destruct mechanism. Called eryptosis, it mirrors the programmed death seen in other cell types but operates without a nucleus. When a red blood cell sustains enough damage from oxidative stress, energy depletion, or toxic exposure, it shrinks and exposes certain molecules on its surface that flag it for removal by macrophages.19PubMed Central. Eryptosis: An Erythrocyte’s Suicidal Type of Cell Death This happens well before the cell would have reached its normal 120-day retirement age.
Eryptosis can be triggered by a wide range of stressors, including certain drugs, heavy metals, infections, and metabolic disturbances. One perspective is that eryptosis actually prevents worse outcomes: by eliminating damaged cells in an orderly way, it avoids the uncontrolled rupture of those cells (hemolysis), which spills free hemoglobin into the blood and can damage the kidneys and blood vessels.20PubMed. Mechanisms of suicidal erythrocyte death When eryptosis is excessive, though, it contributes to anemia because cells are being retired faster than the marrow can replace them.
How Doctors Sort Out the Cause
When a blood test shows you’re anemic, the first question your doctor asks isn’t “why” but “what do the red blood cells look like?” The mean corpuscular volume (MCV) on a standard blood count tells you whether the cells are smaller than normal, normal-sized, or larger than normal. Small cells point toward iron deficiency or thalassemia. Large cells suggest B12 or folate problems. Normal-sized cells with a low count open a wider differential that includes chronic disease, kidney disease, early blood loss, and bone marrow issues.21The Journal of Applied Laboratory Medicine. An Introduction to the Complete Blood Count for Clinical Chemists: Red Blood Cells
From there, an iron panel can confirm or rule out iron deficiency, and a reticulocyte count (which measures how many young red blood cells the marrow is releasing) reveals whether the marrow is responding appropriately. If the marrow is cranking out new cells at a high rate, the problem is likely destruction or loss. If reticulocyte counts are low despite anemia, the marrow itself is underperforming. This branching logic is why even a mild case of anemia sometimes triggers a cascade of follow-up tests: the initial blood count tells you something is wrong, but rarely tells you the whole story.
Malaria and the Evolutionary Shadow on Red Blood Cells
Some of the genetic conditions that cause low red blood cells today evolved because they offered protection against malaria, one of humanity’s deadliest historical threats. Malaria parasites invade and reproduce inside red blood cells, and anything that makes those cells less hospitable to the parasite confers a survival advantage in malaria-endemic regions. Sickle cell trait, thalassemia trait, and G6PD deficiency all reduce the parasite’s ability to thrive, which is why these genes persist at high frequencies in populations from sub-Saharan Africa, the Mediterranean, and Southeast Asia despite causing blood disorders in their more severe forms.22PubMed Central. The ultimate tradeoff: how red cell adaptations to malaria alter the host response during critical illness
The tradeoff is real and ongoing. Carrying one copy of the sickle cell gene provides meaningful malaria resistance, but inheriting two copies causes full sickle cell disease. Mild alpha-thalassemia can actually reduce the severity of sickle cell anemia by lowering the concentration of abnormal hemoglobin inside each cell.12PubMed. Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia These intersections between different red blood cell conditions are a reminder that your genetic background shapes not just whether you develop anemia, but what form it takes and how severe it becomes.
Space Anemia
Here’s one you probably haven’t heard of: astronauts reliably develop anemia during spaceflight. In microgravity, the body senses a fluid shift toward the head and responds by reducing blood volume, destroying red blood cells at an accelerated rate in the process.23PubMed Central. Understanding the complexities of space anaemia in extended space missions: revelations from microgravitational odyssey This so-called space anemia isn’t dangerous during the mission itself because the lower blood volume is proportional. The problem surfaces on return to Earth, when astronauts have to readjust to full gravity with a reduced red blood cell supply. For short missions this resolves within weeks, but extended missions raise concerns about whether the bone marrow can keep up with sustained red blood cell destruction, especially when compounded by cosmic radiation exposure that may further damage blood-forming stem cells. It’s a niche concern for now, but as human space missions grow longer, understanding and preventing space anemia becomes a genuine medical priority.